Cargando…
Targeting the CCL2/CCR2 Axis in Cancer Immunotherapy: One Stone, Three Birds?
CCR2 is predominantly expressed by monocytes/macrophages with strong proinflammatory functions, prompting the development of CCR2 antagonists to dampen unwanted immune responses in inflammatory and autoimmune diseases. Paradoxically, CCR2-expressing monocytes/macrophages, particularly in tumor micro...
Autores principales: | Fei, Liyang, Ren, Xiaochen, Yu, Haijia, Zhan, Yifan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8596464/ https://www.ncbi.nlm.nih.gov/pubmed/34804061 http://dx.doi.org/10.3389/fimmu.2021.771210 |
Ejemplares similares
-
Role of the CCL2-CCR2 axis in cardiovascular disease: Pathogenesis and clinical implications
por: Zhang, Haixia, et al.
Publicado: (2022) -
Preventive CCL2/CCR2 Axis Blockade Suppresses Osteoclast Activity in a Mouse Model of Rheumatoid Arthritis by Reducing Homing of CCR2(hi) Osteoclast Progenitors to the Affected Bone
por: Flegar, Darja, et al.
Publicado: (2021) -
Roles of CCL2-CCR2 Axis in the Tumor Microenvironment
por: Kadomoto, Suguru, et al.
Publicado: (2021) -
Targeting the CCL2-CCR2 axis in depressive disorders
por: Curzytek, Katarzyna, et al.
Publicado: (2021) -
Immuno-cardio-oncology: Killing two birds with one stone?
por: Van Linthout, Sophie, et al.
Publicado: (2022)